NCT01385813
Completed
Not Applicable
Inflammatory Markers in Preeclampsia
Oslo University Hospital0 sites129 target enrollmentJanuary 1999
ConditionsPreeclampsia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Preeclampsia
- Sponsor
- Oslo University Hospital
- Enrollment
- 129
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
This is an investigation of inflammatory markers in women destined to develop preeclampsia.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Caucasian origin
Exclusion Criteria
- •Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Inflammatory Markers in Pregnant Women Destined to Develop PreeclampsiaPreeclampsiaNCT01388283Oslo University Hospital129
Completed
Not Applicable
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.Pre-EclampsiaHELLP SyndromeFetal DeathEclampsiaPlacental AbruptionFetal Growth Retardation, AntenatalNCT03455387Centre Hospitalier Metropole Savoie233
Completed
Not Applicable
Inflammatory Biomarkers for the Diagnosis of oPRESPosterior Reversible Encephalopathy SyndromeInflammatory BiomarkersNeutrophil-lymphocyte RatioNCT05433870Dunjin Chen621
Completed
Not Applicable
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsiaInflammatory MarkersPreeclampsia SeverePreeclampsia MildUmbilical Cord IssueInflammatory ResponseSerum Seromucoid in PregnancyProtein-bound Hexose in PreeclampsiaNCT06712550SHAHLA KAREEM ALALAF204
Suspended
Not Applicable
Preeclampsia: A Marker for Future Cardiovascular Risk in WomenPreeclampsiaPregnancy Induced HypertensionNCT01519297Brigham and Women's Hospital150